| 0.89 | 0.002 | 0.89 | 5 Hydroxytryptamine uptake inhibitor | | |
| 0.769 | 0.003 | 0.769 | Sigma 1 receptor antagonist | | |
| 0.769 | 0.003 | 0.769 | Sigma receptor antagonist | | |
| 0.76 | 0.002 | 0.76 | Dopamine uptake inhibitor | | |
| 0.751 | 0.003 | 0.751 | Histamine H1 receptor antagonist | | |
| 0.704 | 0.004 | 0.704 | Antihistaminic | | |
| 0.7 | 0.004 | 0.7 | Histamine antagonist | | |
| 0.697 | 0.004 | 0.697 | 5 Hydroxytryptamine 2 antagonist | | |
| 0.688 | 0.007 | 0.688 | Spasmolytic | | |
| 0.649 | 0.003 | 0.649 | 5 Hydroxytryptamine 2A antagonist | | |
| 0.619 | 0.014 | 0.619 | Vasodilator, peripheral | | |
| 0.607 | 0.002 | 0.607 | Dopamine transporter inhibitor | | |
| 0.604 | 0.004 | 0.604 | 5 Hydroxytryptamine 2C antagonist | | |
| 0.597 | 0.005 | 0.597 | 5 Hydroxytryptamine antagonist | | |
| 0.578 | 0.008 | 0.578 | Anticonvulsant | | |
| 0.567 | 0.004 | 0.567 | 5 Hydroxytryptamine 2B antagonist | | |
| 0.549 | 0.006 | 0.549 | Sigma receptor agonist | | |
| 0.546 | 0.012 | 0.546 | HERG channel blocker | | |
| 0.521 | 0.013 | 0.521 | Potassium channel (Voltage-sensitive) blocker | | |
| 0.507 | 0.01 | 0.507 | Potassium channel blocker | | |
| 0.499 | 0.004 | 0.499 | Calcium channel blocker | | |
| 0.499 | 0.004 | 0.499 | Acetylcholine M1 receptor antagonist | | |
| 0.473 | 0.005 | 0.473 | Nav1.2 sodium channel blocker | | |
| 0.473 | 0.005 | 0.473 | Dopamine D2 antagonist | | |
| 0.46 | 0.005 | 0.46 | 5 Hydroxytryptamine 1A antagonist | | |
| 0.456 | 0.004 | 0.456 | Adrenaline uptake inhibitor | | |
| 0.456 | 0.006 | 0.456 | Dopamine antagonist | | |
| 0.453 | 0.005 | 0.453 | 5 Hydroxytryptamine 1 antagonist | | |
| 0.448 | 0.004 | 0.448 | Acetylcholine muscarinic antagonist | | |
| 0.443 | 0.006 | 0.443 | Cholinergic antagonist | | |
| 0.436 | 0.004 | 0.436 | Nav1.3 sodium channel blocker | | |
| 0.433 | 0.006 | 0.433 | Acetylcholine antagonist | | |
| 0.446 | 0.037 | 0.446 | 5 Hydroxytryptamine release stimulant | | |
| 0.413 | 0.005 | 0.413 | 5 Hydroxytryptamine 1 agonist | | |
| 0.452 | 0.049 | 0.452 | Histamine release inhibitor | | |
| 0.4 | 0.004 | 0.4 | Calcium channel (voltage-sensitive) blocker | | |
| 0.389 | 0.005 | 0.389 | Dopamine agonist | | |
| 0.388 | 0.01 | 0.388 | Alpha adrenoreceptor antagonist | | |
| 0.371 | 0.005 | 0.371 | Alpha 2b adrenoreceptor antagonist | | |
| 0.367 | 0.003 | 0.367 | Sigma 2 receptor antagonist | | |
| 0.357 | 0.005 | 0.357 | Dopamine D1 antagonist | | |
| 0.361 | 0.008 | 0.361 | Anesthetic local | | |
| 0.369 | 0.028 | 0.369 | Psychostimulant | | |
| 0.346 | 0.005 | 0.346 | Nav1.6 sodium channel blocker | | |
| 0.343 | 0.009 | 0.343 | Antipruritic | | |
| 0.342 | 0.009 | 0.342 | Alpha 1 adrenoreceptor antagonist | | |
| 0.331 | 0.006 | 0.331 | Nav1.1 sodium channel blocker | | |
| 0.362 | 0.049 | 0.362 | Vasodilator, coronary | | |
| 0.309 | 0.007 | 0.309 | Mediator release inhibitor | | |
| 0.322 | 0.026 | 0.322 | Ca(v)3.3 blocker | | |
| 0.342 | 0.055 | 0.342 | Calcium channel activator | | |
| 0.323 | 0.038 | 0.323 | Interleukin agonist | | |
| 0.277 | 0.006 | 0.277 | Alpha 1d adrenoreceptor antagonist | | |
| 0.278 | 0.015 | 0.278 | Antiadrenergic | | |
| 0.268 | 0.006 | 0.268 | 5 Hydroxytryptamine 1A agonist | | |
| 0.276 | 0.015 | 0.276 | Adrenaline antagonist | | |
| 0.26 | 0.004 | 0.26 | Acetylcholine M5 receptor antagonist | | |
| 0.266 | 0.01 | 0.266 | 5 Hydroxytryptamine agonist | | |
| 0.261 | 0.007 | 0.261 | Dopamine D3 antagonist | | |
| 0.253 | 0.004 | 0.253 | Calcium channel T-type blocker | | |
| 0.313 | 0.08 | 0.313 | Antithrombotic | | |
| 0.236 | 0.005 | 0.236 | Interferon agonist | | |
| 0.242 | 0.013 | 0.242 | Alpha 1a adrenoreceptor antagonist | | |
| 0.238 | 0.009 | 0.238 | Calcium antagonist | | |
| 0.237 | 0.01 | 0.237 | Dopamine D4 antagonist | | |
| 0.236 | 0.01 | 0.236 | Calcium channel N-type blocker | | |
| 0.233 | 0.013 | 0.233 | Alpha 2 adrenoreceptor antagonist | | |
| 0.282 | 0.064 | 0.282 | Cardiotonic | | |
| 0.306 | 0.088 | 0.306 | Cholesterol antagonist | | |
| 0.22 | 0.005 | 0.22 | Calcium channel L-type blocker | | |
| 0.217 | 0.012 | 0.217 | Alpha 2a adrenoreceptor antagonist | | |
| 0.209 | 0.006 | 0.209 | Acetylcholine M3 receptor antagonist | | |
| 0.209 | 0.008 | 0.209 | Sphingomyelinase inhibitor | | |
| 0.204 | 0.005 | 0.204 | Histamine H3 receptor antagonist | | |
| 0.203 | 0.005 | 0.203 | Histamine H2 receptor antagonist | | |
| 0.252 | 0.063 | 0.252 | Cyclic AMP phosphodiesterase inhibitor | | |
| 0.203 | 0.017 | 0.203 | Alpha 2c adrenoreceptor antagonist | | |
| 0.343 | 0.159 | 0.343 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | | |
| 0.255 | 0.076 | 0.255 | 5 Hydroxytryptamine uptake stimulant | | |
| 0.217 | 0.04 | 0.217 | 5 Hydroxytryptamine 3E antagonist | | |
| 0.178 | 0.004 | 0.178 | Interferon inducer | | |
| 0.186 | 0.016 | 0.186 | Alpha 1b adrenoreceptor antagonist | | |
| 0.178 | 0.015 | 0.178 | 5 Hydroxytryptamine 7 antagonist | | |
| 0.188 | 0.026 | 0.188 | Interleukin 4 antagonist | | |
| 0.164 | 0.009 | 0.164 | Acetylcholine M2 receptor antagonist | | |
| 0.157 | 0.009 | 0.157 | Dopamine D4 agonist | | |
| 0.146 | 0.002 | 0.146 | GABA uptake inhibitor | | |
| 0.15 | 0.01 | 0.15 | Acetylcholine M4 receptor antagonist | | |
| 0.161 | 0.021 | 0.161 | Multidrug resistance-associated protein 1 inhibitor | | |
| 0.149 | 0.014 | 0.149 | Histamine N-methyltransferase inhibitor | | |
| 0.205 | 0.072 | 0.205 | Neurotrophic factor enhancer | | |
| 0.14 | 0.008 | 0.14 | Glycine transporter 2 inhibitor | | |
| 0.145 | 0.014 | 0.145 | Glutamate (mGluR7) agonist | | |
| 0.192 | 0.069 | 0.192 | P-glycoprotein inhibitor | | |
| 0.118 | 0.004 | 0.118 | 5 Hydroxytryptamine 1D agonist | | |
| 0.123 | 0.011 | 0.123 | 5 Hydroxytryptamine 5A antagonist | | |
| 0.156 | 0.052 | 0.156 | Sphingosine 1-phosphate receptor 5 antagonist | | |
| 0.25 | 0.148 | 0.25 | Immunosuppressant | | |
| 0.103 | 0.004 | 0.103 | Cytokine production stimulant | | |
| 0.112 | 0.013 | 0.112 | 5 Hydroxytryptamine 5 antagonist | | |
| 0.195 | 0.098 | 0.195 | Hypolipemic | | |
| 0.117 | 0.027 | 0.117 | Adrenaline agonist | | |
| 0.163 | 0.073 | 0.163 | Arachidonic acid antagonist | | |
| 0.099 | 0.011 | 0.099 | Dopamine D2 agonist | | |
| 0.261 | 0.173 | 0.261 | Analgesic | | |
| 0.117 | 0.031 | 0.117 | Acetylcholine nicotinic antagonist | | |
| 0.208 | 0.122 | 0.208 | Tyrosine 3 hydroxylase inhibitor | | |
| 0.108 | 0.023 | 0.108 | Estrogen receptor alpha antagonist | | |
| 0.136 | 0.052 | 0.136 | Cholesterol synthesis inhibitor | | |
| 0.114 | 0.031 | 0.114 | Phosphodiesterase 6D inhibitor | | |
| 0.138 | 0.058 | 0.138 | Sphingosine 1-phosphate receptor 2 antagonist | | |
| 0.089 | 0.011 | 0.089 | Ca(v)3.2 blocker | | |
| 0.143 | 0.065 | 0.143 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | | |
| 0.151 | 0.073 | 0.151 | Phospholipase A2 inhibitor | | |
| 0.093 | 0.018 | 0.093 | NMDA 2C receptor antagonist | | |
| 0.105 | 0.03 | 0.105 | Myeloperoxidase inhibitor | | |
| 0.084 | 0.011 | 0.084 | Dopamine D5 antagonist | | |
| 0.101 | 0.031 | 0.101 | NMDA 2 receptor antagonist | | |
| 0.095 | 0.026 | 0.095 | 5 Hydroxytryptamine 1B antagonist | | |
| 0.078 | 0.012 | 0.078 | Potassium channel Kv1.3 blocker | | |
| 0.139 | 0.076 | 0.139 | Ca2+-transporting ATPase inhibitor | | |
| 0.07 | 0.008 | 0.07 | Dopamine beta hydroxylase inhibitor | | |
| 0.107 | 0.046 | 0.107 | Lanosterol 14 alpha demethylase inhibitor | | |
| 0.091 | 0.034 | 0.091 | CC chemokine 5 receptor agonist | | |
| 0.086 | 0.029 | 0.086 | Acetylcholine M5 receptor agonist | | |
| 0.072 | 0.016 | 0.072 | 5 Hydroxytryptamine 1B agonist | | |
| 0.132 | 0.078 | 0.132 | Neurotrophic factor | | |
| 0.071 | 0.018 | 0.071 | Histamine agonist | | |
| 0.194 | 0.142 | 0.194 | MAP kinase kinase 3 inhibitor | | |
| 0.074 | 0.022 | 0.074 | Potassium channel intermediate-conductance Ca-activated blocker | | |
| 0.086 | 0.039 | 0.086 | 5 Hydroxytryptamine 1F antagonist | | |
| 0.068 | 0.022 | 0.068 | Beta 2 adrenoreceptor agonist | | |
| 0.26 | 0.215 | 0.26 | 5 Hydroxytryptamine release inhibitor | | |
| 0.049 | 0.005 | 0.049 | Calcium-sensing receptor antagonist | | |
| 0.113 | 0.068 | 0.113 | Estrogen antagonist | | |
| 0.087 | 0.044 | 0.087 | T cell inhibitor | | |
| 0.063 | 0.019 | 0.063 | Oleamide hydrolase inhibitor | | |
| 0.134 | 0.092 | 0.134 | NOS3 expression enhancer | | |
| 0.059 | 0.02 | 0.059 | Histamine H4 receptor antagonist | | |
| 0.054 | 0.017 | 0.054 | Dopamine D3 agonist | | |
| 0.083 | 0.046 | 0.083 | Nicotinic alpha4beta2 receptor antagonist | | |
| 0.047 | 0.011 | 0.047 | Prostaglandin agonist | | |
| 0.06 | 0.026 | 0.06 | Nicotinic alpha3beta2 receptor antagonist | | |
| 0.169 | 0.135 | 0.169 | ErbB-1 antagonist | | |
| 0.052 | 0.019 | 0.052 | Leukotriene A4 hydrolase inhibitor | | |
| 0.064 | 0.032 | 0.064 | Sphingosine kinase inhibitor | | |
| 0.039 | 0.007 | 0.039 | Prostaglandin E2 agonist | | |
| 0.088 | 0.056 | 0.088 | NMDA receptor antagonist | | |
| 0.04 | 0.008 | 0.04 | Prostaglandin EP2 agonist | | |
| 0.061 | 0.03 | 0.061 | Sphingosine kinase 2 inhibitor | | |
| 0.043 | 0.014 | 0.043 | Ceramide glucosyltransferase inhibitor | | |
| 0.044 | 0.016 | 0.044 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | | |
| 0.058 | 0.031 | 0.058 | Thromboxane synthase inhibitor | | |
| 0.049 | 0.022 | 0.049 | Histamine H2 receptor agonist | | |
| 0.055 | 0.029 | 0.055 | Potassium channel (Inward rectifier) blocker | | |
| 0.091 | 0.07 | 0.091 | Creatine kinase inhibitor | | |
| 0.15 | 0.129 | 0.15 | Platelet aggregation inhibitor | | |
| 0.096 | 0.076 | 0.096 | Toll-Like receptor 4 antagonist | | |
| 0.044 | 0.025 | 0.044 | Heme oxygenase inhibitor | | |
| 0.071 | 0.051 | 0.071 | Phospholipase D inhibitor | | |
| 0.044 | 0.024 | 0.044 | Sphingosine kinase 1 inhibitor | | |
| 0.038 | 0.019 | 0.038 | Prostacyclin antagonist | | |
| 0.052 | 0.034 | 0.052 | 5 Hydroxytryptamine 4 antagonist | | |
| 0.115 | 0.1 | 0.115 | Vanilloid 1 agonist | | |
| 0.036 | 0.021 | 0.036 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | | |
| 0.063 | 0.049 | 0.063 | Beta 3 adrenoreceptor antagonist | | |
| 0.107 | 0.094 | 0.107 | Toll-Like receptor 2 antagonist | | |
| 0.031 | 0.019 | 0.031 | Potassium channel (Inward rectifier) 1 blocker | | |
| 0.053 | 0.042 | 0.053 | Epithelial sodium channel blocker | | |
| 0.077 | 0.067 | 0.077 | Caspase 7 inhibitor | | |
| 0.054 | 0.044 | 0.054 | Alpha 1 adrenoreceptor agonist | | |
| 0.044 | 0.036 | 0.044 | Beta adrenoreceptor agonist | | |
| 0.139 | 0.132 | 0.139 | Non-steroidal antiinflammatory agent | | |
| 0.061 | 0.054 | 0.061 | Beta adrenoreceptor antagonist | | |
| 0.054 | 0.047 | 0.054 | Pregnane X receptor antagonist | | |
| 0.05 | 0.044 | 0.05 | Alpha-mannosidase inhibitor | | |
| 0.09 | 0.084 | 0.09 | Estrogen receptor beta antagonist | | |
| 0.073 | 0.067 | 0.073 | Acetylcholine M3 receptor agonist | | |
| 0.034 | 0.03 | 0.034 | Glutamate (mGluR3) antagonist | | |
| 0.017 | 0.013 | 0.017 | CXC chemokine 5 receptor antagonist | | |
| 0.072 | 0.069 | 0.072 | Viral attachment inhibitor | | |
| 0.05 | 0.048 | 0.05 | 5 Hydroxytryptamine 6 antagonist | | |
| 0.055 | 0.054 | 0.055 | 5 Hydroxytryptamine 1D antagonist | | |
| 0.083 | 0.082 | 0.083 | MAP kinase kinase 1 inhibitor | | |